DCGI

Discussions centred around AI integration, patient centricity, privacy and security in digital health, safety in hospitals,…

Back in February 2020, the Indian government had set a 42-month deadline, culminating on October 1, 2023, for all manufacturers of…

The authorisation is a global first for the age group for the vaccine, which is manufactured and marketed by the Serum Institute…

All necessary approvals from the Indian Council of Medical Research (ICMR) and the Drugs Controller General of India (DCGI) have…

In support of their proposal, Bharat Biotech has submitted updated accelerated and real-time stability data of Coaxin along with…

DCGI's New Year gift of approvals for Covishield, Covaxin for restricted emergency use and ZyCoV-D to start Phase III clinical…

Need to build on the standard principles of AEFI, make it specific to COVID-19 vaccines:Dr V K Paul

HGCO19 is stable at 2-8°C for two months and is supported by DBT, with seed grant under the Ind-CEPI mission

Panned for threatening affected participant with a Rs 100 crore defamation suit

Question if there is an alternative currently to the drug for the treatment of moderate to severe COVID-19 patients